blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2248808

EP2248808 - PROPHYLACTIC OR THERAPEUTIC AGENT FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.05.2015
Database last updated on 25.09.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome Chuo-ku
Osaka- shi, Osaka 541-0045 / JP
[2010/45]
Inventor(s)01 / HIRAI, Keisuke
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
 [2014/29]
Former [2010/45]01 / HIRAI, Keisuke
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85 Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
Representative(s)Dossmann, Gérard, et al
Casalonga & Partners
Bayerstrasse 71-73
80335 München / DE
[2014/29]
Former [2010/45]Dossmann, Gérard, et al
Casalonga & Partners Bayerstrasse 71-73
80335 München / DE
Application number, filing date09705629.530.01.2009
[2010/45]
WO2009JP51658
Priority number, dateJP2008002205931.01.2008         Original published format: JP 2008022059
[2010/45]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009096564
Date:06.08.2009
Language:JA
[2009/32]
Type: A1 Application with search report 
No.:EP2248808
Date:10.11.2010
Language:EN
[2010/45]
Type: B1 Patent specification 
No.:EP2248808
Date:16.07.2014
Language:EN
[2014/29]
Search report(s)International search report - published on:JP06.08.2009
(Supplementary) European search report - dispatched on:EP30.09.2011
ClassificationIPC:C07D307/77, A61K31/343, A61K45/00, A61K45/06, A61P25/14, A61P25/28
[2013/40]
CPC:
A61K31/343 (EP,US); A61K45/06 (EP,US); A61P25/00 (EP);
A61P25/14 (EP); A61P25/28 (EP); A61P43/00 (EP);
C07D307/77 (EP,US); C07D317/60 (EP,US); C07D319/18 (EP,US);
C07D491/048 (EP,US) (-)
C-Set:
A61K31/343, A61K2300/00 (EP,US)
Former IPC [2011/44]C07D307/77, A61K31/343, A61K45/00, A61K45/06, A61P25/14
Former IPC [2010/45]C07D307/77, A61K31/343, A61K45/00, A61P25/14
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/45]
TitleGerman:PROPHYLAKTISCHER ODER THERAPEUTISCHER WIRKSTOFF GEGEN AUFMERKSAMKEITSDEFIZITE UND HYPERAKTIVITÄT[2010/45]
English:PROPHYLACTIC OR THERAPEUTIC AGENT FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER[2010/45]
French:AGENT PROPHYLACTIQUE OU THÉRAPEUTIQUE POUR LE TROUBLE DU DÉFICIT DE L'ATTENTION AVEC HYPERACTIVITÉ[2010/45]
Entry into regional phase30.07.2010Translation filed 
30.07.2010National basic fee paid 
30.07.2010Search fee paid 
30.07.2010Designation fee(s) paid 
30.07.2010Examination fee paid 
Examination procedure30.07.2010Examination requested  [2010/45]
26.04.2012Amendment by applicant (claims and/or description)
25.09.2012Despatch of a communication from the examining division (Time limit: M06)
05.04.2013Reply to a communication from the examining division
04.09.2013Communication of intention to grant the patent
18.12.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
03.02.2014Communication of intention to grant the patent
03.06.2014Fee for grant paid
03.06.2014Fee for publishing/printing paid
03.06.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.09.2012
Opposition(s)17.04.2015No opposition filed within time limit [2015/26]
Fees paidRenewal fee
26.01.2011Renewal fee patent year 03
27.01.2012Renewal fee patent year 04
29.01.2013Renewal fee patent year 05
31.01.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.01.2009
AT16.07.2014
BE16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
HR16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
MK16.07.2014
MT16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
TR16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
IE30.01.2015
LU30.01.2015
[2018/30]
Former [2017/39]HU30.01.2009
AT16.07.2014
BE16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
HR16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
MT16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
TR16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
IE30.01.2015
LU30.01.2015
Former [2017/03]AT16.07.2014
BE16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
MT16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
IE30.01.2015
LU30.01.2015
Former [2016/32]AT16.07.2014
BE16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
IE30.01.2015
LU30.01.2015
Former [2016/07]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
IE30.01.2015
LU30.01.2015
BE31.01.2015
Former [2015/50]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
LU30.01.2015
BE31.01.2015
Former [2015/43]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
LU30.01.2015
BE31.01.2015
Former [2015/39]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
LU30.01.2015
BE31.01.2015
Former [2015/30]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
BE31.01.2015
Former [2015/23]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
Former [2015/22]AT16.07.2014
CY16.07.2014
DK16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
Former [2015/12]AT16.07.2014
CY16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
NL16.07.2014
PL16.07.2014
SE16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
Former [2015/11]CY16.07.2014
FI16.07.2014
LT16.07.2014
PL16.07.2014
SE16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
PT17.11.2014
Former [2015/10]FI16.07.2014
LT16.07.2014
SE16.07.2014
BG16.10.2014
NO16.10.2014
Former [2015/09]FI16.07.2014
LT16.07.2014
SE16.07.2014
Former [2015/08]LT16.07.2014
Documents cited:Search[Y]WO02076452  (POOGER PROPERTIES LTD [GB], et al) [Y] 1-6 * page 1, lines 5-6 * * page 3, line 23 - page 4, line 14 * * page 7, lines 1-5 * * claims 1, 5, 6 *;
 [Y]WO2004028532  (POOGER PROPERTIES LTD [GB], et al) [Y] 1-6 * page 1, lines 4-7 * * page 2, lines 24-33 * * page 5, lines 19-22 * * claims 1, 6 *;
 [Y]WO2007052166  (PASTEUR INSTITUT [FR], et al) [Y] 1-6 * page 4, paragraph 4 * * page 5, paragraph 7 * * example 2 * * claims 29, 33, 34 *;
 [Y]WO9732871  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [Y] 1-6 * page 1, lines 5-7 * * page 7, line 5 - page 8, line 14 * * page 15, lines 34-36; compound (25) * * page 252, lines 39-45 * * claims 1, 24, 34, 35, 40 *
 [Y]  - OWEN RICHARD T, "Ramelteon: Profile of a new sleep-promoting medication", DRUGS OF TODAY, (200604), vol. 42, no. 4, ISSN 1699-3993, pages 255 - 263, XP002659665 [Y] 1-6 * page 256, column 2, paragraph l * * table 1 * * page 261, column 1, paragraph 5 *

DOI:   http://dx.doi.org/10.1358/DOT.2006.42.4.970842
International search[X]JP2007513095  (B & B BEHEER B.V.);
 [X]WO2007025177  (BRAINCELLS INC [US], et al);
 [X]WO2007030697  (BRAINCELLS INC [US], et al);
 [X]WO2006107019  (TAKEDA PHARMACEUTICAL [JP], et al);
 [Y]JP2004527551  (LUNDBECK AS H);
 [Y]WO2006038084  (NEUROCURE LTD [IE], et al);
 [Y]WO2006037996  (MERZ PHARMA GMBH & CO KGAA [DE], et al);
 [XP]US2008167363  (BARLOW CARROLEE [US], et al);
 [XP]WO2008035177  (COPHARM [LU], et al)
Examination   - D. J. CADA, "Formulary Drug Reviews - Ramelteon", HOSPITAL PHARMACY, (2006), vol. 41, no. 1, pages 59 - 69
    - MIYAMOTO MASAOMI ET AL, "Behavioral pharmacology of ramelteon (TAK-375) in small mammals.", ANNALS OF NEUROLOGY, & 128TH ANNUAL MEETING OF THE AMERICAN NEUROLOGICAL ASSOCIATION ON NEUROLOGY OUTCOMES RESEARCH: CURREN; SAN FRANCISCO, CA, USA; OCTOBER 19-22, 2003, (2003), vol. 54, no. Suppl. 7, ISSN 0364-5134, page S46, XP009126297
    - VAN DER HEIJDEN KRISTIAAN B ET AL, "Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia", JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY, (200702), vol. 46, no. 2, ISSN 0890-8567, pages 233 - 241
    - "Diagnostic criteria for Attention-deficit/Hyperactivity disorder", ADHDFamilyOnline, (20000101), pages 1 - 4, URL: http://www.adhdfamilyonline.com/public/images/DSM_Checklist.pdf, (20130722), XP055072207
by applicantUS6034239
 JPH10287665
    - SAGVOLDEN T; RUSSELL VA; AASE H; JOHANSEN EB; FARSHBAF M., "Rodent models of attention-deficit/hyperactivity disorder", BIOL PSYCHIATRY., (2005), vol. 57, no. 11, pages 1239 - 47
    - UENO KI; TOGASHI H; MORI K; MATSUMOTO M; OHASHI S; HOSHINO A; FUJITA T; SAITO H; MINAMI M; YOSHIOKA M., "Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder", BEHAV PHARMACOL., (2002), vol. 13, no. 1, pages 1 - 13
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.